𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term antiviral treatment for recurrent hepatitis C after liver transplantation

✍ Scribed by Valentina Rosa Bertuzzo; Matteo Cescon; Maria Cristina Morelli; Paolo Di Gioia; Mariarosa Tamè; Stefania Lorenzini; Pietro Andreone; Giorgio Ercolani; Massimo Del Gaudio; Matteo Ravaioli; Alessandro Cucchetti; Alessandro Dazzi; Antonietta D’Errico-Grigioni; Antonio Daniele Pinna

Book ID
119230174
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
276 KB
Volume
44
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term antiviral therapy for recurren
Long-term antiviral therapy for recurrent hepatitis C after liver transplantation in nonresponders: Biochemical, virological, and histological impact
✍ Thomas Walter; Jean-Yves Scoazec; Olivier Guillaud; Valérie Hervieu; Philippe Ch 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 1 views

More than 50% of patients with a recurrent posttransplant hepatitis C virus infection fail to respond to antiviral treatment. The aim of this study was to evaluate the interest of a long-term antiviral treatment maintained for more than 48 weeks. Seventy treated patients, with a histological follow-

Antiviral treatment of recurrent hepatit
Antiviral treatment of recurrent hepatitis C after liver transplantation: The need for a multifaceted approach
✍ Didier Samuel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB 👁 1 views

## H epatitis C virus (HCV)-related cirrhosis is currently the leading indication for liver transplantation in Europe and in the United States. 1,2 HCV recurrence after transplantation is almost universal, and 60%-90% of patients will develop lesions of chronic hepatitis C on the graft. 3 The cour